OROPHARYNX CANCER
Clinical trials for OROPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX CANCER trials appear
Sign up with your email to follow new studies for OROPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested for Tough-to-Treat head and neck cancers
Disease control CompletedThis study tested whether combining two existing cancer drugs, pembrolizumab and cetuximab, could help control advanced head and neck cancer that had returned or spread. It involved 78 patients at four US cancer centers, grouped based on their prior treatments. The main goal was …
Matched conditions: OROPHARYNX CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New combo attack on tough head and neck cancers
Disease control CompletedThis study tested whether adding a new immunotherapy drug (pembrolizumab) to the standard treatment of chemotherapy plus radiation could be safe and more effective for people with locally advanced head and neck cancer. All 59 participants received the combined treatment. The main…
Matched conditions: OROPHARYNX CANCER
Phase: PHASE1 • Sponsor: Sanford Health • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Patch tested to help cancer patients speak and swallow after surgery
Symptom relief CompletedThis study looked at whether using a collagen patch during surgery for oral or throat cancer helps patients recover their ability to swallow and speak. 33 patients answered questionnaires about their swallowing and voice before surgery, and again at 1 and 6 months after. The goal…
Matched conditions: OROPHARYNX CANCER
Sponsor: SAYAH Charline • Aim: Symptom relief
Last updated Mar 24, 2026 12:03 UTC
-
Doctors map Cancer's hidden pathways in the neck
Knowledge-focused CompletedThis small study tested a new imaging technique to see how throat cancer spreads to lymph nodes in the neck. Doctors injected a safe, low-level radioactive tracer near the tumor and used a special scanner to track its path. The goal was to gather information to help plan future t…
Matched conditions: OROPHARYNX CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:42 UTC